Teladoc, Lilly and GLP-1s
Teladoc stock jumps on GLP-1 deal with Eli Lilly
Teladoc (TDOC) shares are climbing on Thursday after the healthcare company announced its deal with Eli Lilly's (LLY) direct-to-consumer pharmacy partner Lilly Direct. The deal is set to streamline consumer access to the weight loss drug Zepbound.
(Reuters) -Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss ...
14h
Telemedicine operator Teladoc Health Inc (NYSE:TDOC) has entered a pharmacy integration agreement with Eli Lilly And Co's ...
Teladoc Health (TDOC) announced a pharmacy integration agreement with Eli Lilly’s (LLY) LillyDirect pharmacy partner, Gifthealth, which will ...
The American pharmaceutical company has started selling higher doses of Zepbound, as it seeks to spur demand for the medicine ...
Kelly Bliss, President of U.S. Group Health at Teladoc Health, emphasized the organization’s commitment to expanding access to evidence-based care, stating, "By integrating with LillyDirect, we are ...
(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded ...
Teladoc Health (NYSE: TDOC) today announced a pharmacy integration agreement with Eli Lilly's LillyDirect pharmacy partner, Gifthealth, which will help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback